FGFR3 Receptor clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours
Sorry, in progress, not accepting new patients
This first-in-human study evaluates safety, tolerability and distribution of [225Ac] FPI-1966, [111In]-FPI-1967, and vofatamab in patients with FGFR3-expressing solid tumors.
San Francisco, California and other locations